Northwest, Biotherapeutics

Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk

Northwest Biotherapeutics United Kingdom Maryland

                                                                                          

Les Goldman
240-234-0059
lgoldman@nwbio.com

Logo - https://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc__logo.jpg  

Cision View original content:https://www.prnewswire.co.uk/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021042.html

en | boerse | 67950650 |